Dramamine
Product Images NDC 52904-962

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Dramamine (NDC 52904-962). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Select Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (50 mg Tablet Packet Carton)

Principal Display Panel (50 mg Tablet Packet Carton)
Dramamine motion sickness chewable tablets packaging label by Select Corporation, showing active ingredient dimenhydrinate 50 mg. The label highlights the product as a #1 pharmacist recommended brand, indicating its use for prevention and relief of nausea, dizziness, and vomiting associated with motion sickness. The package contains 25 packets of 2 orange flavor tablets each (50 mg).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.